Efficacy and Adherence of Flexibly Adding on a Second Antimuscarinic Agent for Patients with Refractory Overactive Bladder-Reference-Cited by-同舟云学术

Efficacy and Adherence of Flexibly Adding on a Second Antimuscarinic Agent for Patients with Refractory Overactive Bladder

Published:2015-07-02 Issue:1 Volume:9 Page:27-32
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:Lower Urinary Tract Symptoms

Author:

WANG Chung-Cheng¹²,JIANG Yuan-Hong³,KUO Hann-Chorng³

Affiliation:

1. Department of Urology; En Chu Kong Hospital, College of Medicine, National Taiwan University; New Taipei Taiwan

2. Department of Biomedical Engineering; Chung Yuan Christian University; Taoyuan Taiwan

3. Department of Urology; Buddhist Tzu Chi General Hospital, Tzu Chi University; Hualien Taiwan

Publisher

Wiley

Subject

Urology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/luts.12103/fullpdf

Reference24 articles.

1. Describing bladder storage function: overactive bladder syndrome and detrusor overactivity;Abrams;Urology,2003

2. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

3. A review of adherence to drug therapy in patients with overactive bladder;Basra;BJU Int,2008

4. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan;D'Souza;J Manag Care Pharm,2008

5. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004;Wong;Arch Intern Med,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly;Pharmaceuticals;2023-10-13

2. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Pharmacological Management of Urinary Incontinence: Current and Emerging Treatment;Clinical Pharmacology: Advances and Applications;2021-11

5. Adding mirabegron after intravesical onabotulinumtoxinA injection improves therapeutic effects in patients with refractory overactive bladder;LUTS: Lower Urinary Tract Symptoms;2021-05-06